Nec-1s, 1mg
To Order Contact us: lieven@wlsolutions.be
Nec-1s |
||
| MBS132796-INQUIRE | INQUIRE | Ask for price |
EZSolution? Nec-1s |
||
| 2535-1 | each | EUR 151.2 |
Nec-4 |
||
| HY-18900 | Get quote | Ask for price |
|
Description: Nec-4, a tricyclic derivative, is a potent receptor interacting protein 1 (RIP1) inhibitor, with an IC50 of 2.6 μM, Ki of 0.46 μM. |
||
Nec-4 |
||
| MBS5767185-5mg | 5mg | EUR 915 |
Nec-4 |
||
| MBS5767185-5x5mg | 5x5mg | EUR 3970 |
Nec-4 |
||
| MBS3845466-10mg | 10mg | EUR 1905 |
Nec-4 |
||
| MBS3845466-1mg | 1mg | EUR 430 |
Nec-4 |
||
| MBS3845466-5mg | 5mg | EUR 1165 |
Nec-4 |
||
| MBS3845466-5x10mg | 5x10mg | EUR 8565 |
Nec-4 |
||
| T12202-10mg | 10mg | Ask for price |
|
Description: Nec-4 |
||
Nec-4 |
||
| T12202-1g | 1g | Ask for price |
|
Description: Nec-4 |
||
Nec-4 |
||
| T12202-1mg | 1mg | Ask for price |
|
Description: Nec-4 |
||
Nec-4 |
||
| T12202-50mg | 50mg | Ask for price |
|
Description: Nec-4 |
||
Nec-4 |
||
| T12202-5mg | 5mg | Ask for price |
|
Description: Nec-4 |
||
Nec-3a |
||
| HY-18899 | Get quote | Ask for price |
|
Description: Nec-3a is a Necrostatin-3 analogue. Nec-3a is a RIP1 inhibitor (IC50: 0.44 μM). Nec-3a inhibits the autophosphorylation activity of the RIP1 kinase domain[1]. |
||
(1S,2R)-Tapentadol Hydrochloride (1mg/ml in Acetonitrile) |
||
| KIT7280 | 1x1ml | EUR 800 |
|
Description: 1282502-22-0 |
||
Necrostatin-7 (Nec-7) |
||
| MBS6031043-5mg | 5(mg | EUR 395 |
Necrostatin-7 (Nec-7) |
||
| MBS6031043-5x5mg | 5x5(mg | EUR 1620 |
OPCA00995-1MG - Recombinant human Microtubule-associated protein 1S |
||
| OPCA00995-1MG | 1mg | EUR 1379 |
Recombinant Human Microtubule-associated protein 1S Protein, His, E.coli-1mg |
||
| QP8768-ec-1mg | 1mg | EUR 1958.4 |
7-CL-O-Nec-1 |
||
| MBS516410-25mg | 25mg | EUR 465 |
7-CL-O-Nec-1 |
||
| MBS516410-5mg | 5mg | EUR 225 |
7-CL-O-Nec-1 |
||
| MBS516410-5x25mg | 5x25mg | EUR 1835 |
NOMO-1s |
||
| ABL-TC0480 | 1 vial | Ask for price |
|
Description: NOMO-1s Cell Line is from human; Tissue: hemo-lymphocytic; Morphology: round; Profile: This cell line is useful for studying the differentiation and maturation of monocytes. |
||
IQ-1S |
||
| 526823 | 10.0mg | EUR 90 |
MM.1S |
||
| CSC-C9219W | One Frozen vial | Ask for price |
|
Description: Leukemia - Lymphoma - Myeloma Cells |
||
(1S)-Camphorsultam |
||
| C175125 | 1g | EUR 224 |
|
Description: 94594-90-8 |
||
IQ-1S |
||
| B1279-25 | each | EUR 548.4 |
IQ-1S |
||
| B1279-5 | each | EUR 183.6 |
IQ-1S |
||
| abx282388-100g | 100 µg | Ask for price |
IQ-1S |
||
| abx282388-20g | 20 µg | EUR 118.75 |
IQ-1S |
||
| abx282388-50g | 50 µg | EUR 225 |
IQ-1S |
||
| MBS131364-100mg | 100mg | EUR 1495 |
(1S)-Calcitriol |
||
| HY-10002A | 1 mg | EUR 1623.4 |
|
Description: (1S)-Calcitriol (1α,25-Dihydroxy-3-epi-vitamin-D3) is a natural metabolite of 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3). (1S)-Calcitriol exhibits potent vitamin D receptor (VDR)-mediated actions such as inhibition of keratinocyte growth or suppression of parathyroid hormone secretion[1]. |
||
(1S)-(+)-Myrtenol |
||
| M125410 | 100mg | EUR 621 |
|
Description: 6712-78-3 |
||
IQ-1S |
||
| MBS578494-100mg | 100mg | EUR 345 |
IQ-1S |
||
| MBS578494-10mg | 10mg | EUR 145 |
IQ-1S |
||
| MBS578494-25mg | 25mg | EUR 180 |
IQ-1S |
||
| MBS578494-50mg | 50mg | EUR 240 |
IQ-1S |
||
| MBS578494-5mg | 5mg | EUR 145 |
(1S)-Calcitriol |
||
| MBS5796866-1mg | 1(mg | EUR 1480 |
(1S)-Calcitriol |
||
| MBS5796866-5x1mg | 5x1(mg | EUR 6510 |
(1S)-Chrysanthemolactone |
||
| MBS5761290-1mg | 1mg | EUR 180 |
(1S)-Chrysanthemolactone |
||
| MBS5761290-5x1mg | 5x1mg | EUR 655 |
IQ-1S |
||
| MBS516401-25mg | 25mg | EUR 375 |
IQ-1S |
||
| MBS516401-5mg | 5mg | EUR 205 |
IQ-1S |
||
| MBS516401-5x25mg | 5x25mg | EUR 1440 |
IQ-1S |
||
| MBS3603652-100mg | 100mg | EUR 475 |
IQ-1S |
||
| MBS3603652-10mg | 10mg | EUR 215 |
IQ-1S |
||
| MBS3603652-25mg | 25mg | EUR 265 |
IQ-1S |
||
| MBS3603652-50mg | 50mg | EUR 330 |
IQ-1S |
||
| MBS3603652-5mg | 5mg | EUR 200 |
IQ-1S |
||
| MBS384929-10mg | 10mg | EUR 160 |
IQ-1S |
||
| MBS384929-25mg | 25mg | EUR 230 |
IQ-1S |
||
| MBS384929-50mg | 50mg | EUR 330 |
IQ-1S |
||
| MBS384929-5x50mg | 5x50mg | EUR 1480 |
(1S)-Camphorsultam |
||
| MBS6114899-1g | 1(g | EUR 485 |
(1S)-Camphorsultam |
||
| MBS6114899-5x1g | 5x1g | EUR 2025 |
(1S)-Chrysanthemolactone |
||
| TN2671-10mg | 10mg | Ask for price |
|
Description: (1S)-Chrysanthemolactone |
||
(1S)-Chrysanthemolactone |
||
| TN2671-1g | 1g | Ask for price |
|
Description: (1S)-Chrysanthemolactone |
||
(1S)-Chrysanthemolactone |
||
| TN2671-1mg | 1mg | Ask for price |
|
Description: (1S)-Chrysanthemolactone |
||
(1S)-Chrysanthemolactone |
||
| TN2671-50mg | 50mg | Ask for price |
|
Description: (1S)-Chrysanthemolactone |
||
(1S)-Chrysanthemolactone |
||
| TN2671-5mg | 5mg | Ask for price |
|
Description: (1S)-Chrysanthemolactone |
||
(1S)-Calcitriol |
||
| T35524-10mg | 10mg | Ask for price |
|
Description: (1S)-Calcitriol |
||
(1S)-Calcitriol |
||
| T35524-1g | 1g | Ask for price |
|
Description: (1S)-Calcitriol |
||
(1S)-Calcitriol |
||
| T35524-1mg | 1mg | Ask for price |
|
Description: (1S)-Calcitriol |
||
(1S)-Calcitriol |
||
| T35524-50mg | 50mg | Ask for price |
|
Description: (1S)-Calcitriol |
||
(1S)-Calcitriol |
||
| T35524-5mg | 5mg | Ask for price |
|
Description: (1S)-Calcitriol |
||
BSA, 1mg/mL |
||
| 22070005-1 | 25 mL | EUR 28.77 |
|
Description: Bovine Serum Albumin |
||
BSA, 1mg/mL |
||
| 22070005-2 | 50 mL | EUR 48.08 |
|
Description: Bovine Serum Albumin |
||
BSA, 1mg/mL |
||
| 22070005-3 | 1 mL | EUR 16.16 |
|
Description: Bovine Serum Albumin |
||
Collagen 1mg/ml |
||
| ABP-COL-T1 | 3 x 0,5ml vials | EUR 97.2 |
Carrier RNA 1mg |
||
| CR000001 | each | EUR 3 |
TNF-alpha (Tumor Necrosis Factor alpha)(), 1mg/mL |
||
| BNUM1674-50 | 1uL | EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
||
CD27(203.6), 1mg/mL |
||
| BNUM0163-50 | 50uL | EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
||
CD28(204.12), 1mg/mL |
||
| BNUM0164-50 | 50uL | EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
||
CD46(122.2), 1mg/mL |
||
| BNUM0175-50 | 50uL | EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
||
Growth Medium 1S |
||
| 78221 | 500 ml | EUR 650 |
|
Description: This liquid Growth Medium is a complete medium optimized to culture select BPS Bioscience cell lines.Optimized for Use With: CRISPRa (SAM) HeLa Cell Line (BPS Bioscience, #78193), CRISPRa (SAM) HepG2 Cell Line (BPS Bioscience, #78194) |
||
(1S)-(-)-α-Pinene |
||
| C7097-100 | 100mg | EUR 40 |
|
Description: Membrane Transporter/Ion Channel|GABA Receptor |
||
(1S)-(-)-α-Pinene |
||
| C7097-200 | 200mg | EUR 40 |
|
Description: Membrane Transporter/Ion Channel|GABA Receptor |
||
(1S)-(+)-3-Carene |
||
| C183452 | 100mg | EUR 82 |
|
Description: 498-15-7 |
||
(1S)-(+)-Camphorquinone 99% |
||
| C02185 | 5G | EUR 325.18 |
|
Description: CAS N° 2767-84-2 |
||
(1S,3R)-ACPD |
||
| B6245-10 | 10 mg | EUR 528 |
|
Description: Neuroscience|GluR |
||
(1S,3R)-ACPD |
||
| B6245-50 | 50 mg | EUR 1835.2 |
|
Description: Neuroscience|GluR |
||
(1S,2R)-Bortezomib |
||
| B675710 | 100mg | EUR 81 |
|
Description: 1132709-16-0 |
||
(1S,2S)-Bortezomib |
||
| B675715 | 10mg | EUR 236 |
|
Description: 1132709-14-8 |
||
1S-cis-Bifenthrin |
||
| B382985 | 10mg | EUR 374 |
|
Description: 439680-77-0 |
||
(1S)-trans-Bifenthrin |
||
| B382990 | 10mg | EUR 1777 |
|
Description: 207347-00-0 |
||
RSL3 (1S,3R-) |
||
| MBS131559-100mg | 100mg | EUR 1495 |
(1S,2S)-Bortezomib |
||
| HY-135396 | 1 mg | EUR 378.79 |
|
Description: (1S,2S)-Bortezomib is an enantiomer of Bortezomib. Bortezomib is a cell-permeable, reversible, and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki of 0.6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF-κB. Bortezomib is an anti-cancer agent and the first therapeutic proteasome inhibitor to be used in humans[1][2][3]. |
||
(1S,3R)-ACPD |
||
| HY-100823 | 10mg | EUR 574.68 |
|
Description: (1S,3R)-ACPD is a mGluR agonist that can depolarize pyramidal cells[1]. |
||
(1S,2R)-Alicapistat |
||
| HY-109001A | 10 mg | EUR 4166.73 |
|
Description: (1S,2R)-Alicapistat ((1S,2R)-ABT-957) is an orally active selective inhibitor of human calpains 1 and 2 for the potential application of Alzheimer's disease (AD)[1]. (1S,2R)-Alicapistat mitigates the metabolic liability of carbonyl reduction and inhibits calpain 1 with an IC50 value of 395 nM[2]. |
||
(1S,2R)-Formoterol |
||
| F693405 | 100mg | EUR 11200 |
|
Description: 67346-50-3 |
||
(1S)-(+)-Menthyl chloroformate |
||
| MBS5788617-100mg | 100(mg | EUR 160 |
(1S)-(+)-Menthyl chloroformate |
||
| MBS5788617-5x100mg | 5x100mg | EUR 575 |
(1S)-(-)-Alpha-Pinene |
||
| MBS5759951-5mg | 5mg | EUR 145 |
(1S)-(-)-Alpha-Pinene |
||
| MBS5759951-5x5mg | 5x5mg | EUR 500 |
(1S,3R)-ACPD |
||
| MBS5756991-50mg | 50mg | EUR 1850 |
(1S,3R)-ACPD |
||
| MBS5756991-5x50mg | 5x50mg | EUR 8185 |
(1S,2S)-Bortezomib |
||
| MBS5765873-1mg | 1mg | EUR 190 |
(1S,2S)-Bortezomib |
||
| MBS5765873-2mg | 2mg | EUR 255 |
(1S,2S)-Bortezomib |
||
| MBS5765873-5mg | 5mg | EUR 345 |
Complement 1s (C1s) |
||
| MBS601319-01mL | 0.1mL | EUR 1010 |
Complement 1s (C1s) |
||
| MBS601319-5x01mL | 5x0.1mL | EUR 4395 |
(1S)-(+)-10-Camphorsulfonamide |
||
| MBS6064041-2g | 2(g | EUR 485 |
(1S)-(+)-10-Camphorsulfonamide |
||
| MBS6064041-5x2g | 5x2g | EUR 2025 |
(1S,5R)-(-)-Nopinone |
||
| N825585 | 100mg | EUR 1200 |
|
Description: 77982-63-9 |
||
(1S)-(-)-Alpha-Pinene |
||
| P466610 | 10ml | EUR 272 |
(1S,2S)-Bortezomib |
||
| T10061-10mg | 10mg | Ask for price |
|
Description: (1S,2S)-Bortezomib |
||
(1S,2S)-Bortezomib |
||
| T10061-1g | 1g | Ask for price |
|
Description: (1S,2S)-Bortezomib |
||
(1S,2S)-Bortezomib |
||
| T10061-1mg | 1mg | Ask for price |
|
Description: (1S,2S)-Bortezomib |
||
(1S,2S)-Bortezomib |
||
| T10061-50mg | 50mg | Ask for price |
|
Description: (1S,2S)-Bortezomib |
||
(1S,2S)-Bortezomib |
||
| T10061-5mg | 5mg | Ask for price |
|
Description: (1S,2S)-Bortezomib |
||
1S-epi-Ticagrelor |
||
| T437695 | 100mg | EUR 11200 |
(1S,3R)-Transfluthrin |
||
| T714815 | 1g | EUR 276 |
(1S,3R)-ACPD |
||
| T22488-10mg | 10mg | Ask for price |
|
Description: (1S,3R)-ACPD |
||
(1S,3R)-ACPD |
||
| T22488-1g | 1g | Ask for price |
|
Description: (1S,3R)-ACPD |
||
(1S,3R)-ACPD |
||
| T22488-1mg | 1mg | Ask for price |
|
Description: (1S,3R)-ACPD |
||
(1S,3R)-ACPD |
||
| T22488-50mg | 50mg | Ask for price |
|
Description: (1S,3R)-ACPD |
||
(1S,3R)-ACPD |
||
| T22488-5mg | 5mg | Ask for price |
|
Description: (1S,3R)-ACPD |
||
(1S)-(-)-alpha-Pinene |
||
| TBW01089 | 0.1mL | Ask for price |
(1S,2R)-Alicapistat |
||
| T60150-10mg | 10mg | Ask for price |
|
Description: (1S,2R)-Alicapistat |
||